This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer
Journal of Experimental & Clinical Cancer Research Open Access 02 January 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
van de Haar, J. et al. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. Nat. Med. 29, 605–614 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fyfe, I. Mutations linked to chemotherapy resistance in colorectal cancer. Nat Rev Gastroenterol Hepatol 20, 269 (2023). https://doi.org/10.1038/s41575-023-00772-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-023-00772-5
This article is cited by
-
The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer
Journal of Experimental & Clinical Cancer Research (2024)